Invitrogen Corporation
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 14, 2003

INVITROGEN CORPORATION


(Exact name of registrant as specified in its charter)
         
Delaware   0-25317   33-0373077

 
 
(State or other jurisdiction of incorporation)   (Commission File No.)   (IRS Employer Identification No.)
     
1600 Faraday Avenue, Carlsbad, CA   92008

 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (760) 603-7200

Not Applicable


(Former name or former address, if changed since last report)

 


TABLE OF CONTENTS

Item 5. OTHER EVENTS
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

Item 5. OTHER EVENTS

On August 14, 2003, Invitrogen Corporation (the “Company”) issued a press release regarding the closing of its offering of an additional $25 million aggregate principal amount of 2% Convertible Senior Notes due 2023 pursuant to a 13 day over-allotment option, which has now expired, to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Attached as Exhibit 99.1 is the press release of the Company regarding the additional closing of the offering of the Convertible Senior Notes. Exhibit 99.1 is incorporated by reference under this Item 5.

Item 7. FINANCIAL STATEMENTS AND EXHIBITS.

     (c)  Exhibits.

     
Exhibit   Description

 
99.1   Invitrogen Corporation press release dated August 14, 2003 regarding the additional closing of the offering of convertible senior notes.

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

           
    Invitrogen Corporation
         
Date: August 18, 2003   By:   /s/ John A. Cottingham
       
        John A. Cottingham
Vice President, General Counsel & Secretary

 


Table of Contents

EXHIBIT INDEX

     
Exhibit   Description

 
99.1   Invitrogen Corporation press release dated August 14, 2003 regarding the additional closing of the offering of convertible senior notes.